Your healthcare provider will typically prescribe the lowest dose first and gradually increase it over time
GLP-1 medications work in part by slowing digestion, which helps people feel full longer and reduces overall calorie intake
Gastrointestinal adverse effects represent the most commonly observed side effects of Semaglutide / Cyanocobalamin Injection, occurring in a substantial proportion of patients, particularly during the initial weeks of treatment or following dose escalations
Most marketed "drops" claim sublingual or buccal absorption, but there is little peer-reviewed evidence that offlabel compounded drops deliver consistent, therapeutic blood levels
Maximum Loss In retatrutide trials, individuals lost up to 24% of their original weight
The type 2 diabetes mellitus segment led the market with a 58% share in 2025, driven by the large existing diabetic patient population